Histopathology of urothelial carcinomas. Crucial for patient management;Histopathologie des harnblasenkarzinoms. Entscheidend für das management der betroffenen patienten

Urologe - Ausgabe A

Volumn 47, Issue 5, 2008, Pages 627-638

  Lindemann Docter, K ^a   Knuchel Clarke R ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Carcinoma in situ; Diagnosis; Infiltrating urothelial carcinoma; Noninvasive papillary urothelial neoplasia; WHO classification

Indexed keywords

BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CARCINOGENESIS; CARCINOMA IN SITU; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; GENE MUTATION; HEREDITY; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MOLECULAR GENETICS; PAPILLOMA; REVIEW; UROGENITAL TRACT TUMOR; WORLD HEALTH ORGANIZATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BIOPSY; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; PRECANCEROUS CONDITIONS; PROGNOSIS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 44149083733     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-008-1736-z     Document Type: Review

References (13)

1. Eble JN, Sauter G, Epstsein JI et al. (eds) (2004) Tumors of the urinary system and male genital tract. WHO classification of tumours. Pathology & genetics. IARC Press, Lyon
2. Epstein JI, Amin MB, Reuter VE (eds) (2004) Bladder biopsy interpretation. Lippincott Williams & Wilkins, Philadelphia
3. Grignon DJ (1997) Neoplasms of the urinary bladder. In: Bostwick DG, Eble JE (eds) Urological surgical pathology. Mosby-Year Book, St Louis, pp 214-305
4. Hafner C, Knuechel R, Zanardo L et al. (2001) Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract.Oncogene 20: 4910-4915
5. Hafner C, Knuechel R, Stoehr R et al. (2002) Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies. Int J Cancer 101: 1-6
6. Hungerhuber E, Stepp H, Kriegmair M et al. (2007) Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology 69: 260-264
7. Jones TD, Cheng L (2006) Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts. J Urol 175: 1995-2003
8. Leissner J, Hohenfellner R, Thüroff JW et al. (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. Br J Urol 85: 817-823
9. 3 CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors. Cancer Res 66: 7401-7404
10. Mitra AP, Datar RH, Cote RJ (2006) Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol 24: 5552-5564
11. Obermann EC, Junker K, Stoehr R et al. (2003) Frequent genetic alterations in flat urothelial hyperplasia and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses. J Pathol 199: 50-57
12. Stoehr R, Hartmann A (2007) Histopathologie und Molekulargenetik des Harnblasenkarzinoms. Onkologe 12: 1058-1066
13. Stoehr R, Knuechel R, Boecker J et al. (2002) Histologic-genetic mapping by allele-specific PCR reveals intraurothelial spread of p53 mutant tumor clones. Lab Invest 82: 1553-1561